1999
DOI: 10.1016/s0009-9120(98)00099-x
|View full text |Cite
|
Sign up to set email alerts
|

Clinical significance of plasma HDL subfractions (HDL2, HDL3) in patients with peripheral arterial disease (PAD) in the Greek population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
5
0

Year Published

2003
2003
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 28 publications
2
5
0
Order By: Relevance
“…In the Cardiovascular Health Study (2), the same increment of HDL-cholesterol was associated with a 15% lower prevalence of low AAI. These findings are consistent in that HDL-cholesterol levels were reduced in patients with peripheral arterial disease (27).…”
Section: Discussionsupporting
confidence: 84%
“…In the Cardiovascular Health Study (2), the same increment of HDL-cholesterol was associated with a 15% lower prevalence of low AAI. These findings are consistent in that HDL-cholesterol levels were reduced in patients with peripheral arterial disease (27).…”
Section: Discussionsupporting
confidence: 84%
“…Due to statin treatment, plasma TC and LDL‐C levels were significantly decreased in all PAD patients compared to N subjects (Table 2). HDL‐C levels in all PAD patients were significantly lower than in N subjects, in good agreement with previous reports 19,20 . TG concentrations were increased in all PAD patients compared to N subjects.…”
Section: Resultssupporting
confidence: 92%
“…The data regarding HDL 2 and HDL 3 composition in PAD patients are scarce. It was reported that HDL 2 ‐C, HDL 3 ‐C, and their major protein, ApoAI, are significantly reduced in PAD patients compared to normal subjects 19,20 . PON1 activity plays an important role in conferring antioxidant properties to HDL 21,22 .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…High-density lipoprotein structure (as measured by subfraction concentration) is associated with CVD risk ( 15 , 16 ), and measurement of HDL function (as measured by HDL-C efflux capacity) has emerged as a robust marker of prevalent and incident CVD ( 17 ). The clinical significance and profile of HDL subfractions in patients with PAD are also not well understood with reports of both increased ( 18 ) and decreased ( 19 ) HDL3 levels in the setting of reduced HDL2 and HDL-C. The HDL subfractions, HDL2 and HDL3, are particles with unique size and density that may have distinct cholesterol efflux capacities ( 20 ), exhibit unique efflux responses to drug therapy ( 21 ), and have differential associations with CVD events ( 22 ).…”
Section: Introductionmentioning
confidence: 99%